NCT03205748

Brief Summary

Ascites refers to fluid that accumulates within the peritoneal cavity. Although ascites is most commonly observed in patients with cirrhosis and resulting portal hypertension (approximately 85% of cases), 7% to 10% of patients with ascites develop secondary to a malignancy

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 2, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2018

Completed
Last Updated

November 29, 2017

Status Verified

November 1, 2017

Enrollment Period

1 year

First QC Date

June 29, 2017

Last Update Submit

November 28, 2017

Conditions

Ascites

Outcome Measures

Primary Outcomes (1)

  • The percentage of patients with malignant ascites

    according to laboratory and clinical criteria

    1 month

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients will be recruited from Departments of Internal Medicine, Assiut university tertiary hospital.

You may qualify if:

  • Patients with ascites
  • serum ascites albumin gradient \>1.1.

You may not qualify if:

  • ascitic fluid serum ascites albumin gradient \<1.1.
  • Haemorrgaic ascites;
  • chylous ascites

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut Faculty of Medicine

Asyut, Egypt

RECRUITING

MeSH Terms

Conditions

Ascites

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

June 29, 2017

First Posted

July 2, 2017

Study Start

August 1, 2017

Primary Completion

August 1, 2018

Study Completion

November 1, 2018

Last Updated

November 29, 2017

Record last verified: 2017-11

Locations

EG(1)